BioCorRx Inc. (OTCMKTS:BICX) Short Interest Update

BioCorRx Inc. (OTCMKTS:BICX) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totalling 800 shares, a growth of 100.0% from the March 31st total of 400 shares. Based on an average daily trading volume, of 2,800 shares, the short-interest ratio is presently 0.3 days.

BioCorRx Stock Performance

Shares of BioCorRx stock traded down $0.07 during trading hours on Friday, reaching $0.75. The company’s stock had a trading volume of 902 shares, compared to its average volume of 1,508. BioCorRx has a one year low of $0.67 and a one year high of $2.22. The company has a market capitalization of $6.67 million, a P/E ratio of -1.67 and a beta of 0.59. The stock’s fifty day simple moving average is $1.02 and its two-hundred day simple moving average is $1.07.

BioCorRx (OTCMKTS:BICX) last released its quarterly earnings data on Monday, April 1st. The company reported ($0.11) earnings per share for the quarter. The business had revenue of $0.02 million for the quarter.

BioCorRx Company Profile

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.